Haematology Diagnostics Market - Forecasts from 2019 to 2024

November 2019 | 111 pages | ID: HB67609A4FD1EN
Knowledge Sourcing Intelligence LLP

Abstracts

Increasing prevalence of blood disorders and rising blood donation are considered as the key drivers for the growth of the market. Rising healthcare awareness along with the rapidly growing geriatric population also fuels the growth of the market. According to leukaemia and lymphoma society in every 3 minutes, one person in the United States (USA) is diagnosed with blood cancer. However slow adoption of haematology instruments in the developing economies is considered as the restraining factor for the growth of the market.

The haematology diagnostics market is expected to grow from a market size of USD3.418 billion in 2018 to attain a market size of USD8.418 billion with an impressive CAGR of 16.21%. Geographically, the North American region is expected to hold a significant market share due to the early adoption of technology and the highest health expenditure of the United States among the developed regions of the world followed by the Asia Pacific region, which is expected to be the fastest-growing. Furthermore, technological advancements in the field of haematology analyzers are also expected to drive the growth of the market during the forecast period and in the upcoming years.

The Haematology Diagnostics Market – Forecasts from 2019 to 2024 is an exhaustive study which aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, component, platform, and geography.

The haematology diagnostics market has been segmented based on technology, end-user, and geography. Based on technology, the market has been segmented into electrical impedence, flow cytometry, and fluorescent flow cytometry. By end-user, the market is segmented as hospitals and clinics, research and academic institutes, and diagnostic centers.

Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa (MEA), and the Asia Pacific regions. The report also analyzes 15 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.

Major players in the haematology diagnostics market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the haematology diagnostics market.

Segmentation

The haematology diagnostics market has been analyzed through the following segments:

• By Technology
• Electrical Impedence
• Flow Cytometry
• Fluorescent Flow Cytometry
• By End User
• Hospitals and Clinics
• Research and Academic Institutes
• Diagnostic Centers
• By Geography
• North America
• United States of America
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Italy
• Others
• Middle East and Africa
• Israel
• Saudi Arabia
• Others
• Asia Pacific
• China
• Japan
• India
• South Korea
• Others

Contents

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Secondary Sources

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
  4.5.1. Bargaining Power of Suppliers
  4.5.2. Bargaining Power of Buyers
  4.5.3. Threat of New Entrants
  4.5.4. Threat of Substitutes
  4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis- Regional Snapshot
4.7. Market Attractiveness

5. HAEMATOLOGY DIAGNOSTICS MARKET BY TECHNOLOGY

5.1. Electrical Impedence
5.2. Flow Cytometry
5.3. Fluorescent Flow Cytometry

6. HAEMATOLOGY DIAGNOSTICS MARKET BY END USER

6.1. Hospitals and Clinics
6.2. Research and Academic Institutes
6.3. Diagnostic Centers

7. HAEMATOLOGY DIAGNOSTICS MARKET BY GEOGRAPHY

7.1. North America
  7.1.1. United States of America
  7.1.2. Canada
  7.1.3. Mexico
7.2. South America
  7.2.1. Brazil
  7.2.2. Argentina
  7.2.3. Others
7.3. Europe
  7.3.1. United Kingdom
  7.3.2. Germany
  7.3.3. France
  7.3.4. Italy
  7.3.5. Others
7.4. Middle East and Africa
  7.4.1. United Arab Emirates
  7.4.2. Israel
  7.4.3. Saudi Arabia
  7.4.4. Others
7.5. Asia Pacific
  7.5.1. China
  7.5.2. Japan
  7.5.3. India
  7.5.4. South Korea
  7.5.5. Others

8. COMPETITIVE INTELLIGENCE

8.1. Competitive Benchmarking and Analysis
8.2. Recent Investments and Deals
8.3. Strategies of Key Players

9. COMPANY PROFILES

9.1. Bio-Rad Laboratories, Inc.
9.2. Boule Diagnostics AB
9.3. Abbott
9.4. Diatron
9.5. Biosystems S.A.
9.6. F. Hoffmann-La Roche Ltd
9.7. Horiba, Ltd.
9.8. Erba Diagnostics Mannheim GmbH
9.9. Ortho Clinical Diagnostics
9.10. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
9.11. EKF Diagnostics Holdings plc